Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

11.40
Delayed Data
As of 3:04pm ET
 +0.65 / +6.05%
Today’s Change
7.33
Today|||52-Week Range
13.70
-6.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$266.7M

Company Description

Zogenix, Inc. is a pharmaceutical company, which engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. It develops two products candidate: ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Contact Information

Zogenix, Inc.
5858 Horton Street
Emeryville California 94608
P:(510) 550-8300
Investor Relations:

Employees

Shareholders

Other institutional56.59%
Mutual fund holders32.84%
Individual stakeholders1.02%

Top Executives

Stephen J. FarrPresident, Chief Executive Officer & Director
Michael P. SmithCFO, Secretary, Treasurer & Executive VP
Bradley S. GalerChief Medical Officer & Executive Vice President
Steven A. JohnsonVice President & Compliance Officer
Gail M. FarfelChief Development Officer & Executive VP